TM4SF1 and colorectal cancer: Several early experiences with CAR T cell therapy in colorectal cancer include phase I trials investigating targets such as transmembrane 4 L six family member 1 (TM4SF1) and epithelial cell adhesion molecule (EpCAM), which are both highly expressed in many epithelial‐derived solid tumors.